Pernix Therapeutics Stock Price (NASDAQ:PTX)

Add to My Stocks
$2.49 $0.03 (1.22%) PTX stock closing price Mar 22, 2018 (Closing)
Prev Close* : $2.46
Market Cap:
Day Low: $2.41
52 Week Low: $2.00
Open: $2.45
Volume: -
Day High: $2.52
52 Week High: $7.15

Latest Stock Market News

Latest Articles

Pernix Therapeutics News - From Partners

Pernix Therapeutics Announces Sale of Non-Core Product   by Globe Newswire on Nov 06, 2017

PTX Stockcharts

View PTX PE ratio, PS ratio stocks charts and compare with peers.
PTX Chart
Note: Compare Pernix Therapeutics stock price history with the index and industry peers.

Pernix Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Pernix Therapeutics Returns

(return on equity)

Pernix Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PTX Industry Peers

Company Price Change (%)
Versartis (VSAR)1.70.1 (5.56%)
Evoke Pharma (EVOK)2.070 (0%)
Cumberland Pharma (CPIX)6.750.06 (0.88%)
Vanda Pharmaceuticals (VNDA)16.950 (0%)
Depomed (DEPO)6.60.01 (0.15%)
Eli Lilly (LLY)76.531.71 (2.19%)
Durect (DRRX)2.230.04 (1.83%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)3.530.32 (9.97%)
AEVI GENOMIC (GNMX)2.030.06 (3.05%)
Aquinox Pharma (AQXP)14.550.11 (0.76%)
AxoGen (AXGN)39.550.15 (0.38%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 23, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)24.461.34 (5.19%)
Mylan (MYL)39.871.29 (3.13%)
Dr. Reddy's Laboratories (RDY)32.370.8 (2.41%)
Mallinckrodt (MNK)14.310.26 (1.78%)
Teva Pharmaceutical (TEVA)17.310.29 (1.65%)
Impax Lab (IPXL)20.50.25 (1.2%)
Corium (CORI)11.520.08 (0.69%)
Top losers from Medical-Generic Drugs industry
* As of Mar 23, 2018

Pernix Therapeutics Holdings Inc Stock News - Partner Headlines

Pernix Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues140.85M175.85M121.74M84.87M61.31M
Net Income-169.59M-148.31M-35.28M-25.63M-1.41M
Total Operating Expense237.84M225.68M106.78M95.64M38.89M
View Pernix Therapeutics income statement
balance sheet20162015201420132012
Total Assets310.44M511.15M487.41M211.38M251.44M
Total Liabilities424.5M478.06M403.82M100.66M172.9M
Shareholders Equity-114.06M33.09M83.59M110.72M78.53M
View Pernix Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities22.73M-4.23M10.48M21.84M-5.48M
Net Cash from (used by) Operating Activities-16.5M-14.74M8.89M-6.53M-1.92M
Increase (Decrease) in Prop Plant And Equipment-0.98M-1.21M-1.13M19.09M-0.31M
View Pernix Therapeutics cash flow statement

Pernix Therapeutics Stock Message Board

Pernix Therapeutics stock gained 1.22%, and the last close price as of Mar 22, 2018 is $2.49 for PTX stock. Stock price or share price can be used to find the total market value of a company. Pernix Therapeutics market cap stands at $29.21M as of Mar 22, 2018. Pernix Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Pernix Therapeutics is worth a lot, it will most likely be reflected in an inflated Pernix Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Pernix Therapeutics stock quote data shows the number of shares traded. For Ex: 100,795 Pernix Therapeutics shares were traded as of last trading day, as seen from Pernix Therapeutics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Pernix Therapeutics does not pay dividends. Pernix Therapeutics stock price history, gives the entire historical data for PTX stock.